NCT02366871 Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy Status COMPLETED Phase PHASE2
NCT02363868 Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population Status COMPLETED Phase N/A
NCT02362659 Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry Status COMPLETED Phase N/A
NCT02357732 Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib Status WITHDRAWN Phase PHASE1
NCT02353780 Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept Status TERMINATED Phase PHASE4
NCT02350764 Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs Status COMPLETED Phase PHASE2
NCT02350114 An Observational Study of the Functional Capacity of Heart Failure Status COMPLETED Phase NA
NCT02343042 Selinexor and Backbone Treatments of Multiple Myeloma Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02341638 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02341625 A Study of BMS-986148 in Patients With Select Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02339818 Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries Status COMPLETED Phase N/A
NCT02335918 A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02335606 Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan Status COMPLETED Phase N/A
NCT02329847 A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02327403 Belatacept Conversion in Proteinuric Kidney Transplant Recipients Status COMPLETED Phase PHASE2
NCT02327273 Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02327078 A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) Status COMPLETED Phase PHASE1/PHASE2